Phillips 66 (PSX)

Phillips 66 closed at $258.68 after a 3.18% gain, but the stock still trades 3.68% below its 50-day average and 2.91% below its 20-day EMA, leaving its short-term trend mixed. The longer picture is strong: the price sits 27.05% above its 200-day average and the one-year return is 83.66%. Analysts are constructive, with 11 of 20 rating the stock buy or strong buy and a median 12-month target of $297.00. CleaRank rates the stock Buy with a score of 77/100, the same as the consensus.

The trend reading is mixed. The price is above its 200-day average of $203.61 by 27.05%, and the 50-day SMA of $268.56 sits 27.05% above that 200-day average, so the long-term structure is firmly up. But the price is 3.68% below the 50-day SMA and 2.91% below the 20-day EMA, which means the stock has slipped under its shorter averages after a strong run. The one-month return of minus 8.10% shows that pullback, while the six-month gain of 50.55% and the one-year gain of 83.66% show how far the stock has come.

The October 28, 2026 report showed EPS of $14.08 on an adjusted basis against an analysts' estimate of $11.79, a beat of 19.42%. The shares rose 1.95% in the first session after that report. Across the last eight reports, seven beat the EPS estimate and one missed. The record matters because the stock's reaction has not always followed the beat: two of the seven beats were followed by a lower share price in the first session, and three of the eight reports overall saw the shares fall in that session.

The stock trades on a trailing P/E of 8.30, a 54.9% discount to the sector median of 18.4, and a price-to-sales ratio of 0.60 against a sector median of 2.5. The net profit margin of 7.48% is thin by comparison, and debt-to-equity of 0.52 is moderate. The analysts' figures point the other way on growth: they expect revenue to grow 23.5% this fiscal year but EPS to shrink 7.1% next fiscal year.

Of 20 analysts with a current rating, 11 rate the stock buy or strong buy, 8 hold it and 1 sells it. Three months ago 12 of 20 rated it buy, so the buy count has edged down. Recent actions included Citigroup keeping its Neutral rating on November 4, 2026, Morgan Stanley keeping its Overweight rating on November 2, 2026, and two Freedom Broker upgrades to Hold from Sell on October 30 and October 31, 2026. Over the last 18 months, insiders sold $67.1M of stock across 23 sales and bought $1.3M across six open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than open-market buying.

The base case is that PSX keeps its longer-term uptrend while it works through the moving averages above the price. For that to hold, the stock needs to reclaim the 20-day EMA and then the 50-day SMA, which would show the short-term trend turning in its favour. Earnings momentum is the main support: the last report beat the estimate by 19.42%, and analysts' average EPS estimate for this fiscal year is $34.76. Analysts expect EPS to shrink 7.1% next fiscal year, to $32.28, so the case weakens if quarterly results fall back toward the analysts' estimates or if the price loses the 200-day SMA at $203.61. The analysts' median target of $297.00 sits 14.8% above the price, and the range runs from $188.00 to $350.00. Those targets are analysts' forecasts, not guarantees. A simulation based on past volatility is not a forecast, and the stock's typical daily move of 2.59% means sharp swings remain normal.

Support sits at the 200-day SMA at $203.61, the nearest level below the price, and a break there would bring the 52-week low at $127.16 into view as the next floor. Resistance comes first from the 20-day EMA at $266.44, the nearest level above the price, followed by the 50-day SMA at $268.56, which is the level that has to be cleared to restore a clear short-term uptrend. Beyond that, the 52-week high at $299.39 is the next ceiling and the level the stock would have to pass to set a new high.